G-CSF therapy as an adjunct to reperfusion therapy in the...

Details G-CSF therapy as an adjunct to reperfusion therapy in the... G-CSF therapy as an adjunct to reperfusion therapy in the...

2007-05-22

2007-05-22

Andres, Janet L. (Department: 1647)

Drug, bio-affecting and body treating compositions

Lymphokine

C424S085200, C435S001200, C514S012200

Reexamination Certificate

active

10694579

ABSTRACT:
The present invention relates to methods of using Granulocyte Colony Stimulating Factor (G-CSF) polypeptide in conjunction with reperfusion therapy in the treatment of acute myocardial infarction or other ischemic events. This treatment can be used alone or in combination with other well-known methods of treatment.

REFERENCES:
patent: 4810643 (1989-03-01), Souza
patent: 4904584 (1990-02-01), Shaw
patent: 5104651 (1992-04-01), Boone et al.
patent: 5214132 (1993-05-01), Kuga et al.
patent: 5218092 (1993-06-01), Sasaki et al.
patent: 5362853 (1994-11-01), Kuga et al.
patent: 5606024 (1997-02-01), Boone et al.
patent: 5824778 (1998-10-01), Ishikawa et al.
patent: 5824784 (1998-10-01), Kinstler et al.
patent: 6017876 (2000-01-01), Gegg et al.
patent: 6166183 (2000-12-01), Ishikawa et al.
patent: 6261550 (2001-07-01), Osslund
patent: 2002/0061587 (2002-05-01), Anversa
patent: 2003/0064922 (2003-04-01), Nissen et al.
patent: A-76380/91 (1991-11-01), None
patent: A-10948/92 (1992-08-01), None
patent: 0 243153 (1987-10-01), None
patent: 0 256843 (1988-02-01), None
patent: 0 272703 (1988-06-01), None
patent: 0 335423 (1989-10-01), None
patent: 0 370205 (1990-05-01), None
patent: 0 401384 (1990-12-01), None
patent: 0 456200 (1991-11-01), None
patent: 0 459630 (1991-12-01), None
patent: 0 473268 (1992-03-01), None
patent: 1129720 (2001-09-01), None
patent: 1327449 (2003-07-01), None
patent: WO 88/00969 (1988-02-01), None
patent: WO 89/05824 (1989-06-01), None
patent: WO 89/10932 (1989-11-01), None
patent: WO 90/06952 (1990-06-01), None
patent: WO 90/12874 (1990-11-01), None
patent: WO 91/05798 (1991-05-01), None
patent: WO 91/11520 (1991-08-01), None
patent: WO 91/18911 (1991-12-01), None
patent: WO 92/04455 (1992-03-01), None
patent: WO 92/06116 (1992-04-01), None
patent: WO 92/06707 (1992-04-01), None
patent: WO 93/05169 (1993-03-01), None
patent: WO 93/15211 (1993-08-01), None
patent: WO 94/20069 (1994-09-01), None
patent: WO 95/21629 (1995-08-01), None
patent: WO 96/11953 (1996-04-01), None
patent: WO 01/51510 (2001-07-01), None
patent: WO 03/006501 (2003-01-01), None
patent: WO 03/030821 (2003-04-01), None
Vallely et al., The J of Thoracic and Cardiovascular Surgery, vol. 124(4): pp. 758-767, esp. p. 761, Figure 1.
Hiltunen, et al. Nerve growth factor and brain-derived neurotrophic factor mRNAs are regulated in distinct cell populations of rat heart after ischaemia and reperfusion. J Pathol. Jun. 2001;194(2):247-53.
Gottlieb et al., Apoptosis in myocardial ischemia-reperfusion. Ann N Y Acad Sci. Jun. 30, 1999;874:412-26. Review.
Melillo et al., Intrinsic Myocyte Dysfunction and Tryrosine Kinase Pathway Activation Underlie the Imparied Wall Thickening of Adjacent Regions During Postinfarct Left Venricular Remodeling. 1996 Circulation 93:1447-58.
Stedman's Medical Dictionary 27th Edition, 2000 Lippincott Williams & Wilkins.
Kukielka et al., Interleukin-8 Gene Induction in the Myocardium after Ischemia and Reperfusion in Vivo. J Clin Invest. Jan. 1995 95:89-103.
Colquhoun et al., Reversal of neutropenia with granulocyte colony-stimulating factor without precipitating liver allograft rejection,Transplantation56:755-758, 1993.
Diflo et al., Simultaneous use of ganciclovir and granulocyte colony stimulating factor in liver transplant recipients,Hepatology16:PA278A, 1992.
Ferrari, et al., Muscle regeneration by bone marrow-derived myogenic progenitors,Science279:1528-1530, 1998.
Fukunaga et al., Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor,Cell74:1079-1087, 1993.
Gabrilove, Introduction and overview of hematopoietic growth factors,Semin. Hematol.26:2 (Suppl 2):1-4, 1989.
Görgen et al., Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-α,J. Immunol.149:918-924, 1992.
Jones et al., Growth factors in haemopoiesis,Bailliere's Clin. Hematol.2:83-111, 1989.
Kocher et al., Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function,Nature Med.7:430-436, 2001.
Kuga et al., Mutagenesis of human granulocyte colony stimulating factor,Biochem. Biophys. Res. Comm.159:103-111, 1989.
Lachaux et al., Treatment with lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) and orthotopic liver transplantation for glycogen storage disease type lb,J. Ped.123:1005-1008, 1993.
Lange et al., Reperfusion therapy in acute myocardial infarction,N. Engl. J. Med.346:954-955, 2002.
Lu et al., Disulfide and secondary structures of recombinant human granulocyte colony stimulating factor,Arch. Biochem. Biophys.268:81-92, 1989.
Moore et al., Synergy of interleukin 1 and granulocyte colony-stimulating factor: In vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice,Proc. Natl. Acad. Aci. USA84:7134-7138, 1987.
Orlic et al., Bone marrow cells regenerate infarcted myocardium,Nature(London) 410:701-705, 2001.
Orlic et al., Mobilized bone marrow cells repair the infarcted heart, improving function and survival,Proc. Nat. Acad. Sci USA98:10344-10347, 2001.
Orlic et al., Adult bone marrow stem cells regenerate myocardium in ischemic heart disease,Ann. N.Y. Acad. Sci.996: 152-157, 2003.
Rosenthal et al., Bone marrow-derived angioblasts may be used to promote cardiac revascularization in the days following a myocardial infarction,Nature Medicine7:412-413, 2001.
Souza et al., Recombinant human granulocyte colony-stimulating factor: Effects on normal and leukemic myeloid cells,Science232:61-65, 1986.
Takano et al., Pleiotropic effects of cytokines on acute myocardial infarction: G-CSF as a novel therapy for acute myocardial infarction,Curr. Pharm. Des.9.1121-1127, 2003.
Welte et al., Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor,Proc. Natl. Acad. Sci. USA82: 1526-1530, 1985.
Wright et al., Granulocyte colony-stimulating factor (GCSF) combined with αinterferon (αIFN) for treatment of liver allograft recipients with viral hepatitis,Hepatology14:PA48, 1991.
Ambler et al., “Integration of bone marrow-derived stem cells into infracted myocardium following ischemia-reperfusion in mice,” Abstract No. 413.7,FASEB Journal17:4-5, 2003.
Engelmann et al., “Placebo-controlled, randomized, double-blind study on the efficacy of bone-marrow stem cell mobilization induced by granulocyte-colony stimulating factor (G-CSF) on improvement of ischemic heart failure undergoing delayed revascularization for ST segment elevation myocardial infarction (STEM),” Abstract No. 2829,Circulation108 (17) Suppl.:IV-622, 2003.
Goltermann, “Reperfusion of acute coronary syndromes and myocardial infarction,”Air Medical Journal19:47-49, 2000.
Hellström-Lindberg et al., “Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: Results from a randomized phase II study and long-term follow-up of 71 patients,”Blood92:68-75, 1998.
Kuramochi et al., “Granulocyte-colony stimulating factor (G-CSF) administeration improves cardiac function after myocardial infarction in mice without altering cardiomyocyte regeneration,” Abstract No. 99,Circulation, 106:19 (Suppl.): 11-20, 2002.
Li et al., “Efficiency of granulocyte colony stimulating factor (G-CSF) on cardiac function and cytokines in rat model acute myocardial infarction,” Abstract No. 3P-0648,Artherosclerosis Supplements, 4 (2):204, 2003.
Mehta et al., “Early administration of a filgrastim following experimental myocardial infarction in a porcine ischemia reperfusion model may help myocardial repair,” Abstract No. 4328, Blood 102:154b-155b, 2003.
Minatoguchi et al., “Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac f

Affiliated with

Also associated with

Rating

G-CSF therapy as an adjunct to reperfusion therapy in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with G-CSF therapy as an adjunct to reperfusion therapy in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and G-CSF therapy as an adjunct to reperfusion therapy in the... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3793676